Literature DB >> 25762785

Coexpression of TIGIT and FCRL3 identifies Helios+ human memory regulatory T cells.

Khalid Bin Dhuban1, Eva d'Hennezel1, Emil Nashi2, Amit Bar-Or3, Sadiye Rieder4, Ethan M Shevach4, Satoshi Nagata5, Ciriaco A Piccirillo6.   

Abstract

Two distinct subsets of CD4(+)Foxp3(+) regulatory T (Treg) cells have been described based on the differential expression of Helios, a transcription factor of the Ikaros family. Efforts to understand the origin and biological roles of these Treg populations in regulating immune responses have, however, been hindered by the lack of reliable surface markers to distinguish and isolate them for subsequent functional studies. Using a single-cell cloning strategy coupled with microarray analysis of different Treg functional subsets in humans, we identify the mRNA and protein expression of TIGIT and FCRL3 as a novel surface marker combination that distinguishes Helios(+)FOXP3(+) from Helios(-)FOXP3(+) memory cells. Unlike conventional markers that are modulated on conventional T cells upon activation, we show that the TIGIT/FCRL3 combination allows reliable identification of Helios(+) Treg cells even in highly activated conditions in vitro as well as in PBMCs of autoimmune patients. We also demonstrate that the Helios(-)FOXP3(+) Treg subpopulation harbors a larger proportion of nonsuppressive clones compared with the Helios(+)FOXP3(+) cell subset, which is highly enriched for suppressive clones. Moreover, we find that Helios(-) cells are exclusively responsible for the productions of the inflammatory cytokines IFN-γ, IL-2, and IL-17 in FOXP3(+) cells ex vivo, highlighting important functional differences between Helios(+) and Helios(-) Treg cells. Thus, we identify novel surface markers for the consistent identification and isolation of Helios(+) and Helios(-) memory Treg cells in health and disease, and we further reveal functional differences between these two populations. These new markers should facilitate further elucidation of the functional roles of Helios-based Treg heterogeneity.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25762785      PMCID: PMC4610024          DOI: 10.4049/jimmunol.1401803

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

Review 1.  Fc receptor-like proteins (FCRL): immunomodulators of B cell function.

Authors:  Götz R A Ehrhardt; Chuen-Miin Leu; Shuangyin Zhang; Güzide Aksu; Tanisha Jackson; Chris Haga; Joyce T Hsu; Daniel M Schreeder; Randall S Davis; Max D Cooper
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

2.  Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity.

Authors:  Noriko Komatsu; Maria Encarnita Mariotti-Ferrandiz; Ying Wang; Bernard Malissen; Herman Waldmann; Shohei Hori
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-27       Impact factor: 11.205

3.  DNA methylation controls Foxp3 gene expression.

Authors:  Julia K Polansky; Karsten Kretschmer; Jennifer Freyer; Stefan Floess; Annette Garbe; Udo Baron; Sven Olek; Alf Hamann; Harald von Boehmer; Jochen Huehn
Journal:  Eur J Immunol       Date:  2008-06       Impact factor: 5.532

4.  Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development.

Authors:  Marc A Gavin; Troy R Torgerson; Evan Houston; Paul DeRoos; William Y Ho; Asbjørg Stray-Pedersen; Elizabeth L Ocheltree; Philip D Greenberg; Hans D Ochs; Alexander Y Rudensky
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-14       Impact factor: 11.205

5.  Foxp3 inhibits RORgammat-mediated IL-17A mRNA transcription through direct interaction with RORgammat.

Authors:  Kenji Ichiyama; Hideyuki Yoshida; Yu Wakabayashi; Takatoshi Chinen; Kazuko Saeki; Mako Nakaya; Giichi Takaesu; Shohei Hori; Akihiko Yoshimura; Takashi Kobayashi
Journal:  J Biol Chem       Date:  2008-04-23       Impact factor: 5.157

6.  The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells.

Authors:  Xin Yu; Kristin Harden; Lino C Gonzalez; Michelle Francesco; Eugene Chiang; Bryan Irving; Irene Tom; Sinisa Ivelja; Canio J Refino; Hilary Clark; Dan Eaton; Jane L Grogan
Journal:  Nat Immunol       Date:  2008-11-16       Impact factor: 25.606

7.  Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.

Authors:  Sarah E Allan; Sarah Q Crome; Natasha K Crellin; Laura Passerini; Theodore S Steiner; Rosa Bacchetta; Maria G Roncarolo; Megan K Levings
Journal:  Int Immunol       Date:  2007-02-27       Impact factor: 4.823

8.  CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells.

Authors:  Weihong Liu; Amy L Putnam; Zhou Xu-Yu; Gregory L Szot; Michael R Lee; Shirley Zhu; Peter A Gottlieb; Philipp Kapranov; Thomas R Gingeras; Barbara Fazekas de St Groth; Carol Clayberger; David M Soper; Steven F Ziegler; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

9.  Epigenetic control of the foxp3 locus in regulatory T cells.

Authors:  Stefan Floess; Jennifer Freyer; Christiane Siewert; Udo Baron; Sven Olek; Julia Polansky; Kerstin Schlawe; Hyun-Dong Chang; Tobias Bopp; Edgar Schmitt; Stefan Klein-Hessling; Edgar Serfling; Alf Hamann; Jochen Huehn
Journal:  PLoS Biol       Date:  2007-02       Impact factor: 8.029

10.  Expansion of human regulatory T-cells from patients with type 1 diabetes.

Authors:  Amy L Putnam; Todd M Brusko; Michael R Lee; Weihong Liu; Gregory L Szot; Taumoha Ghosh; Mark A Atkinson; Jeffrey A Bluestone
Journal:  Diabetes       Date:  2008-12-15       Impact factor: 9.461

View more
  54 in total

1.  Linc-POU3F3 promotes cell proliferation in gastric cancer via increasing T-reg distribution.

Authors:  Guanying Xiong; Lihua Yang; Yun Chen; Zhining Fan
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

2.  Helios+ and Helios- Treg subpopulations are phenotypically and functionally distinct and express dissimilar TCR repertoires.

Authors:  Angela M Thornton; Jinghua Lu; Patricia E Korty; Yong Chan Kim; Craig Martens; Peter D Sun; Ethan M Shevach
Journal:  Eur J Immunol       Date:  2019-01-15       Impact factor: 5.532

3.  Pathogenic Transdifferentiation of Th17 Cells Contribute to Perpetuation of Rheumatoid Arthritis during Anti-TNF Treatment.

Authors:  Karin M E Andersson; Nicola Filluelo Cavallini; Dan Hu; Mikael Brisslert; Ron Cialic; Hadi Valadi; Malin C Erlandsson; Sofia Silfverswärd; Rille Pullerits; Vijay K Kuchroo; Howard L Weiner; Maria I Bokarewa
Journal:  Mol Med       Date:  2015-06-04       Impact factor: 6.354

4.  Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226.

Authors:  Christopher A Fuhrman; Wen-I Yeh; Howard R Seay; Priya Saikumar Lakshmi; Gaurav Chopra; Lin Zhang; Daniel J Perry; Stephanie A McClymont; Mahesh Yadav; Maria-Cecilia Lopez; Henry V Baker; Ying Zhang; Yizheng Li; Maryann Whitley; David von Schack; Mark A Atkinson; Jeffrey A Bluestone; Todd M Brusko
Journal:  J Immunol       Date:  2015-05-20       Impact factor: 5.422

5.  Stable inhibitory activity of regulatory T cells requires the transcription factor Helios.

Authors:  Hye-Jung Kim; R Anthony Barnitz; Taras Kreslavsky; Flavian D Brown; Howell Moffett; Madeleine E Lemieux; Yasemin Kaygusuz; Torsten Meissner; Tobias A W Holderried; Susan Chan; Philippe Kastner; W Nicholas Haining; Harvey Cantor
Journal:  Science       Date:  2015-10-16       Impact factor: 47.728

Review 6.  Multiple Sclerosis and T Lymphocytes: An Entangled Story.

Authors:  Laurine Legroux; Nathalie Arbour
Journal:  J Neuroimmune Pharmacol       Date:  2015-05-07       Impact factor: 4.147

Review 7.  Regulatory T cells in acute and chronic kidney diseases.

Authors:  Rahul Sharma; Gilbert R Kinsey
Journal:  Am J Physiol Renal Physiol       Date:  2017-09-06

8.  TIGIT and Helios Are Highly Expressed on CD4+ T Cells in Sézary Syndrome Patients.

Authors:  Neha Jariwala; Bernice Benoit; Andrew V Kossenkov; Landon K Oetjen; Timothy M Whelan; Christine M Cornejo; Junko Takeshita; Brian S Kim; Louise C Showe; Maria Wysocka; Alain H Rook
Journal:  J Invest Dermatol       Date:  2016-09-01       Impact factor: 8.551

9.  Increased islet antigen-specific regulatory and effector CD4+ T cells in healthy individuals with the type 1 diabetes-protective haplotype.

Authors:  Xiaomin Wen; Junbao Yang; Eddie James; I-Ting Chow; Helena Reijonen; William W Kwok
Journal:  Sci Immunol       Date:  2020-02-14

Review 10.  Promises and paradoxes of regulatory T cells in inflammatory bowel disease.

Authors:  James D Lord
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.